Batoclimab shows promise for thyroid eye disease in extension study
NCT ID NCT05517447
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people who finished earlier trials of batoclimab for thyroid eye disease. It has two parts: one watches how long benefits last without treatment, and the other gives batoclimab to see if it helps more patients. The goal is to see if the drug can control eye bulging and other symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- batoclimab
- What this could lead to
- If successful, this could show that batoclimab helps control thyroid eye disease symptoms longer and in more patients.
- What could go wrong
- This trial was terminated early, so results may be limited. It's an extension study, meaning it builds on earlier work, and the drug may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Site Number - 1501
Aurora, Colorado, 80045, United States
-
Site Number - 1508
Houston, Texas, 77030, United States
-
Site Number - 1511
Morgantown, West Virginia, 26506, United States
-
Site Number - 1513
Rochester, Minnesota, 55905, United States
-
Site Number - 1518
Milwaukee, Wisconsin, 53226, United States
-
Site Number - 1520
Glendora, California, 91741, United States
-
Site Number - 1526
Livonia, Michigan, 48152, United States
-
Site Number - 1540
Las Vegas, Nevada, 89184, United States
-
Site Number - 1558
Mesquite, Texas, 75149, United States
-
Site Number - 1990
San Juan, 00921, Puerto Rico
-
Site Number - 3101
Krakow, 30-688, Poland
-
Site Number - 3104
Lublin, 20-171, Poland
-
Site Number - 3105
Lublin, 60-354, Poland
-
Site Number - 3107
Gliwice, Silesian Voivodeship, 44-102, Poland
-
Site Number - 3450
Tbilisi, 159, Georgia
-
Site Number - 3451
Tbilisi, 159, Georgia
-
Site Number - 3454
Tbilisi, 114, Georgia
-
Site Number - 3455
Tbilisi, 114, Georgia
-
Site Number - 3600
Santiago de Compostela, 15706, Spain
-
Site Number - 3602
Barcelona, Catalonia, 8006, Spain
-
Site Number - 3603
Valencia, 46026, Spain
-
Site Number - 3604
Madrid, 28034, Spain
-
Site Number - 3606
Seville, 41009, Spain
-
Site Number - 4670
Ghent, B-9000, Belgium
-
Site Number - 4671
Bruges, 8000, Belgium
-
Site Number - 4672
Brussels, 1070, Belgium
-
Site Number - 4673
Brussels, 1200, Belgium
-
Site Number - 4760
Ramat Gan, Tel Aviv, 5265601, Israel
-
Site Number - 4761
Jerusalem, 91120, Israel
-
Site Number - 4762
Petah Tikva, 4941492, Israel
-
Site Number - 4764
Afula, 1834111, Israel
-
Site Number - 6201
Pisa, 56124, Italy
-
Site Number - 6202
Rome, 00189, Italy
-
Site Number - 6203
Milan, 20149, Italy
-
Site Number - 6204
Milan, 20122, Italy
-
Site Number - 6205
Naples, 80131, Italy
-
Site Number - 6207
Catania, CAP95125, Italy
-
Site Number - 6209
Palermo, 90127, Italy
-
Site Number - 7300
Manchester, M139WL, United Kingdom
-
Site Number - 7302
Newcastle upon Tyne, NE1 3BZ, United Kingdom
-
Site Number - 7303
London, EC1V 2PD, United Kingdom
-
Site Number - 7305
Guildford, GU2 7XX, United Kingdom
-
Site Number - 7308
Sheffield, S102SB, United Kingdom
-
Site Number - 7312
London, W1T 6AH, United Kingdom
-
Site Number - 7313
London, W1T 7HA, United Kingdom
-
Site Number - 7550
Budapest, 1133, Hungary
-
Site Number - 7552
Pécs, 7623, Hungary
-
Site Number - 7565
Sydney, 2000, Australia
-
Site Number - 7570
Christchurch, 8013, New Zealand
-
Site Number - 9200
Bratislava, 82606, Slovakia
-
Site Number - 9201
Bratislava, Slovakia
-
Site Number - 9202
Trenčín, 91101, Slovakia
-
Site Number - 9300
Riga, LV-1006, Latvia
-
Site Number - 9301
Ogre, LV-5001, Latvia
-
Site Number - 9302
Ventspils, LV3601, Latvia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted antibody calm thyroid eye disease?
- Could a cholesterol drug shrink eye muscle swelling in thyroid eye disease?
- Can an experimental drug reduce eye bulging in thyroid eye disease?
- Can a new drug ease bulging eyes in thyroid disease?
- New drug IBI3031 enters first human trial for thyroid eye disease
- New hope for thyroid eye disease: drug shows promise in Steroid-Resistant patients